Most recently, it has been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to the wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions as a scavenger https://deborahf034zqe4.howeweb.com/profile